Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.
- DOI
- 10.1093/cid/ciae364
- Published
- 2024 Oct 15
- Container
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/cid/ciae364,
title = {Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.},
author = {Ferguson M and Schwarz TF and Núñez SA and Rodríguez-García J and Mital M and Zala C and Schmitt B and Toursarkissian N and Mazarro DO and Großkopf J and Voors-Pette C and Mehta H and Hailemariam HA and de Heusch M and Salaun B and Damaso S and David MP and Descamps D and Hill J and Vandermeulen C and Hulstrøm V and RSV OA=ADJ-018 Study Group},
year = {2024},
journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
doi = {10.1093/cid/ciae364},
url = {https://doi.org/10.1093/cid/ciae364}
}RIS
TY - JOUR TI - Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age. AU - Ferguson M AU - Schwarz TF AU - Núñez SA AU - Rodríguez-García J AU - Mital M AU - Zala C AU - Schmitt B AU - Toursarkissian N AU - Mazarro DO AU - Großkopf J AU - Voors-Pette C AU - Mehta H AU - Hailemariam HA AU - de Heusch M AU - Salaun B AU - Damaso S AU - David MP AU - Descamps D AU - Hill J AU - Vandermeulen C AU - Hulstrøm V AU - RSV OA=ADJ-018 Study Group PY - 2024 JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America DO - 10.1093/cid/ciae364 UR - https://doi.org/10.1093/cid/ciae364 ER -
APA
M, F., TF, S., SA, N., J, R., M, M., C, Z., B, S., N, T., DO, M., J, G., C, V., H, M., HA, H., M, D. H., B, S., S, D., MP, D., D, D., J, H., C, V., V, H., & Group, R. O. S. (2024). Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciae364
Source records
- pubmed · retrieved 2026-09-26T07:34:03.004Z